Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
The ExteNET Study & Management of HER2+ Breast Cancer
Exploratory Analysis of ExteNET Trial Shows Consistency of Benefit With ...
Estudo ExteNET avalia o uso neratinibe em pacientes com câncer de mama ...
Final Efficacy Results From the ExteNET Trial Neratinib in Pretreated ...
Our Story | Extenet
Adjuvant Neratinib and Pertuzumab; ExteNET and APHINITY Data
ExteNet Systems Reveals New Brand as Extenet - JSA
Extenet Announces Appointment of New Chief Revenue Officer
Extenet's new digital infrastructure Suite | Extenet posted on the ...
Extenet's Fiber Connectivity Solutions | Extenet posted on the topic ...
EMPIRE STATE BUILDING CASE STUDY SUMMARY | PDF
Case Studies - Extenet
The ExteNET Trial
A Canadian real-world, multi-center, prospective, observational study ...
Contact Us | Extenet
Mobility Networks | Extenet
Home | Extenet
What We Do | Extenet
Extenet Simplifies Telecom Monetization with RecVue | RecVue posted on ...
LOGO
Anti-HER2 Therapies in Breast Cancer | PPTX
Frontiers | The Conundrum of Adjuvant HER2 Treatment Options
Neratinib as extended adjuvant therapy in patients with copositive ...
Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor ...
Overall survival with neratinib after trastuzumab-based adjuvant ...
(PDF) Neratinib as extended adjuvant therapy in patients with ...
ADC-Overview-and-Application.v7.20201117.pptx
(PDF) PIK3CA alterations and benefit with neratinib: Analysis from the ...
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive ...
Figure 3 from Final Efficacy Results of Neratinib in HER2-positive ...
Figure 2 from Extended Adjuvant Therapy with Neratinib Plus Fulvestrant ...
Figure 2 from Final Efficacy Results of Neratinib in HER2-positive ...
(PDF) Effects of neratinib on health-related quality of life in women ...
[PDF] Extended Adjuvant Therapy with Neratinib Plus Fulvestrant Blocks ...
Figure 1 from Neratinib after trastuzumab-based adjuvant therapy in ...
Differences in adjusted mean changes from baseline between treatment ...
Diarrhoea over time with neratinib without systematic prophylaxis ...
(PDF) Final Efficacy Results of Neratinib in HER2-positive Hormone ...
Position Paper on the Value of Extended Adjuvant Therapy with Neratinib ...
Early-stage treatment │ NERLYNX® (neratinib) tablets
PIK3CA alterations and benefit with neratinib: analysis from the ...
Evolving Standards in HER2-Targeted Adjuvant Therapy (Transcript)
Kaplan-Meier plot of 5-year invasive disease-free survival for patients ...
(PDF) Timing of initiation of neratinib after trastuzumab-based ...
Eur J Cancer:来那替尼（Neratinib）延伸辅助治疗在HER2/HR共阳性早期乳腺癌患者的疗效和安全性分析：来自德国 ...
(PDF) Neratinib after trastuzumab-based adjuvant therapy in patients ...
Neratinib
How to Optimise Extended Adjuvant Treatment with Neratinib for Patients ...
Optimal Strategies for Successful Initiation of Neratinib in Patients ...
Neratinib after trastuzumab-based adjuvant therapy in patients with ...
Figure 1 from Improved tolerability of neratinib in patients with HER2 ...
Table 2 from Neratinib after trastuzumab-based adjuvant therapy in ...
Figure 3 from Neratinib after trastuzumab-based adjuvant therapy in ...
Table 3 from Neratinib after trastuzumab-based adjuvant therapy in ...
Extended Adjuvant Therapy with Neratinib Plus Fulvestrant Blocks ER ...
Table 1 from Final Efficacy Results of Neratinib in HER2-positive ...
Improved tolerability of neratinib in patients with HER2-positive early ...
Neratinib: A Crucial Component of Targeted Treatment for CNS Metastases ...
Effects of neratinib on health-related quality of life in women with ...
106 Extended Adjuvant Neratinib in HER2+/HR+ Early Breast Cancer in ...
HER2+早期乳腺癌的“T～N”双靶策略——ExteNET研究最终分析-肿瘤瞭望
Baseline patient characteristics in the intention-to-treat (ITT ...
(PDF) 177PEffects of neratinib (N) on health-related quality of life ...
(PDF) Patterns of occurrence and implications of neratinib-associated ...
王晓稼教授：HER2阳性乳腺癌强化辅助治疗新模式探讨（附幻灯）丨杭州湘湖国际乳腺癌峰会-肿瘤瞭望
Neratinib in Early-Stage Breast Cancer: A Profile of Its Use in the EU ...
Oncologists See Promise in Neratinib, New Oral HER2-Positive Drug
HER2+早期乳腺癌的“T～N”双靶策略——ExteNET研究最终分析-搜狐大视野-搜狐新闻
ASCO: Adjuvant neratinib has payoff in HER2-positive breast cancer ...
2020 CCO丨王永胜教授：HER2阳性早期乳腺癌多临床决策点-肿瘤瞭望
JLE - Innovations & Thérapeutiques en Oncologie - Vers une réduction du ...
Neratinib - wikidoc
ExteNET: 5-year invasive disease-free survival analysis. Adapted from ...
廖宁教授：HER2阳性乳腺癌关键临床研究汇总|阳性乳腺癌|曲妥珠单抗|HER2|乳腺癌|临床|研究|治疗|-健康界
Recommendations for neoadjuvant and adjuvant therapy for HER2 positive ...
HER2＋早期乳腺癌的“T～N”双靶策略——ExteNET研究最终分析_腾讯新闻
Optimal extension time after initial endocrine therapy for ...
CANbridge Pharmaceuticals Receives Marketing Approval for NERLYNX ...
11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2 ...
ExteNET: 5-year invasive disease-free survival analysis by hormone ...
Adjuvant endocrine therapy in HER2-positive breast cancer patients ...
Puma Biotechnology Presents Interim Results of Phase II CONTROL Trial ...
Transforming the Sports and Entertainment Industry with Extenet’s Best ...
Frontiers | Extended adjuvant endocrine therapy for women with hormone ...
HER2阳性早期乳腺癌的治愈“艺术”__财经头条
Emerging treatments in HER2-positive advanced breast cancer: Keep ...
Six-Year Survival Outcomes for Patients with HER2-Positive Early Breast ...
30717-9/asset/a2a99010-9873-4d37-b7b6-e8dc858ca559/main.assets/gr1.gif)
-(1).jpg?download=1)
